CO-FOUNDER & CEO

Emily Man has led Venova Technologies as Co-Founder & CEO since inception. Emily is the recipient and PI on one NIH SBIR/STTR Phase II grant, two NIH SBIR/STTR Phase I grants, and two NICHD X01 service contracts. She is also Co-Investigator on two state grants with Boston Medical Center.

Emily has worked in several medical device industries, including orthopedic implants, advanced stenting technologies, heart valve implants, and rehabilitative exoskeleton devices. Her academic and industry experience span healthcare, biomechanics and mechanobiology, cancer biomarker research, cell therapy, and include contributions to the first IND clearance from the FDA for a multiplex-base edited investigational drug.

Emily holds a BS and MS in Bioengineering/Biomedical Engineering from Northeastern University, where she received a Presidential Global Scholarship, College of Engineering Distinguished Scholar Award, and Bioengineering Trailblazer Award.